Aura Biosciences Competitors and Similar CompaniesClear all
Aura Biosciences's competitors and similar companies include Takeda, Biocon, Shanghai Junshi Biosciences and Takeda Oncology.
 Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. |  Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. | ||
Founding Date | Founding Date 2009 | Founding Date 1781 | Founding Date 1978 | Founding Date 2012 | Founding Date 1993 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ | Locations Cambridge, US HQ | |
Employees | Employees 42 | Employees 47,4554% decrease | Employees 16,5612% increase | Employees 2,578 | Employees 1,6441% decrease |
Valuation ($) | Valuation ($) 544.2 m | Valuation ($) 43.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥466.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥2b (FY, 2025) | Gross profit N/A |
Net income | Net income ($106.2m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income ₹3.7b (FY, 2026) | Net income (¥1b) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 213.9m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View companyTakeda Oncology
HQ
Cambridge, US
Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View company